MedTrace Logo

Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting

NCT02756234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2018-12-06

No results posted yet for this study

Summary

The objective of this study is to carefully monitor all patients undergoing Computed Tomographic Perfusion (CTP) at Lancaster General Hospital for safety, and determine the efficiency of the CTP procedure in a community setting.

Conditions

Sponsors & Collaborators

  • Toshiba America Medical Systems, Inc.

    collaborator INDUSTRY

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Lancaster General Hospital

    lead OTHER

Principal Investigators

  • Ron Jacob, MD · Lancaster General Health / Penn Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2018-08-30
Completion
2018-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02756234 on ClinicalTrials.gov